Abstract Submission Rules

  • Abstracts must be submitted in English. No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. Their names and affiliations (institutions) will be registered separately when submitting the abstract online.

  • Failure to comply with the following requirements will lead to automatic rejection of the submission:
    • Use generic names. The use of commercial drug names, brands and registered trademarks are strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation.
    • No mention of pharmaceutical company names should be included in the abstract.

  • The tile should be the same as the one inserted in the session programme sent to the EADV headquarters. The title should not be written entirely in capital letters (e.g. NOT LIKE THIS).

  • The size of the abstract is limited to 3,000 characters (this includes title, body of abstract, spaces, tables and graphics). The submission program will automatically calculate the size of your abstract and will not allow submissions that do not fit in the size requirements.

  • You can click on the relevant icons to insert tables, pictures or specific characters.

  • Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted.